Osaic Holdings
NVCR icon

Osaic Holdings’s NovoCure NVCR Stock Holding History

Osaic Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.5K Buy
3,718
+1,085
+41% +$13.6K ﹤0.01% 5369
2025
Q4 		$34K Sell
2,633
-640
-20% -$8.22K ﹤0.01% 5509
2025
Q3 		$41.1K Buy
3,273
+47
+1% +$628 ﹤0.01% 5440
2025
Q2 		$57.4K Buy
3,226
+321
+11% +$5.59K ﹤0.01% 4950
2025
Q1 		$51.8K Buy
2,905
+208
+8% +$4.72K ﹤0.01% 4693
2024
Q4 		$80.4K Buy
2,697
+652
+32% +$13.8K ﹤0.01% 4356
2024
Q3 		$32K Sell
2,045
-430
-17% -$7.8K ﹤0.01% 5057
2024
Q2 		$42.4K Sell
2,475
-2,373
-49% -$41.7K ﹤0.01% 4806
2024
Q1 		$75.8K Sell
4,848
-1,203
-20% -$17.7K ﹤0.01% 4441
2023
Q4 		$90.3K Sell
6,051
-841
-12% -$11.3K ﹤0.01% 4505
2023
Q3 		$111K Sell
6,892
-627
-8% -$18.1K ﹤0.01% 4427
2023
Q2 		$312K Sell
7,519
-359
-5% -$22.3K ﹤0.01% 3551
2023
Q1 		$476K Sell
7,878
-1,456
-16% -$116K ﹤0.01% 3133
2022
Q4 		$684K Sell
9,334
-929
-9% -$69.9K ﹤0.01% 2742
2022
Q3 		$780K Sell
10,263
-1,328
-11% -$104K ﹤0.01% 2458
2022
Q2 		$807K Sell
11,591
-35
-0.3% -$2.64K ﹤0.01% 2488
2022
Q1 		$938K Buy
11,626
+654
+6% +$48.2K ﹤0.01% 2631
2021
Q4 		$826K Buy
10,972
+2,042
+23% +$205K ﹤0.01% 2576
2021
Q3 		$1.04M Sell
8,930
-9,980
-53% -$1.51M ﹤0.01% 2316
2021
Q2 		$4.16M Buy
18,910
+9,597
+103% +$1.87M 0.01% 1150
2021
Q1 		$1.23M Sell
9,313
-9,665
-51% -$1.53M ﹤0.01% 2045
2020
Q4 		$3.28M Sell
18,978
-4,304
-18% -$589K 0.01% 1098
2020
Q3 		$2.54M Buy
23,282
+13,353
+134% +$1.07M 0.01% 1169
2020
Q2 		$590K Sell
9,929
-45,099
-82% -$2.97M ﹤0.01% 2185
2020
Q1 		$2.33M Buy
+55,028
New +$4.35M 0.01% 994

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Osaic Holdings's NVCR Position: Q1 2026 in Review

Osaic Holdings increased its NovoCure (NVCR) stake by 41% in Q1 2026, buying an estimated $13.6K and bringing the position to 3,718 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5369.

Osaic Holdings first reported a position in NVCR in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.16M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Osaic Holdings held 3,718 shares of NovoCure worth $40.5K as of Q1 2026.
  • Osaic Holdings bought 1,085 NovoCure shares in Q1 2026, an estimated $13.6K.
  • NovoCure made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5369 holding.
  • Osaic Holdings first reported a position in NovoCure in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's NovoCure position peaked at $4.16M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.